HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Yongjiang Yu
The People's Hospital of Tongliang District, China
UBE2A binding to WAC through the ATR/CHK1 axis facilitates DNA damage repair, resulting in PARP inhibitor resistance in ovarian cancer